Fibrosis progression after liver transplantation in patients with recurrent hepatitis C

被引:28
作者
Feray, C [1 ]
机构
[1] INSERM, U481, Paris, France
关键词
D O I
10.1016/j.jhep.2004.09.002
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Aim of our study was to analyze fibrosis progression after liver transplantation (OLT) in hepatitis C virus (HCV)-infected patients based on protocol liver biopsies and to identify risk factors, which may play a role in the development of severe fibrosis stages. One hundred and eighty-three liver graft recipients who had a histological follow-up evaluation of 1 year after OLT were analyzed. Overall 1039 protocol liver biopsies were performed after 1-, 3-, 5-, 7- and 10 years and staged according to the Scheuer score. The fibrosis progression rate was not linear. The fibrosis scores were 1.2 after one, 1.7 after three, 1.9 after five, 2.1 after 7 and 2.2 after 10 years. The 39 recipients with fibrosis stages 3 or 4 in the 1-year biopsy had a significantly reduced survival rate, while fibrosis stage 0-2 indicated excellent survival. Independent risk factors for progression of fibrosis at 1 year were HCV genotype 1 and 4 (P=0.01) and donor age>33 years (P=0.01), whereas risk factors for development of cirrhosis (30/183 recipients (16%)) were donor age (P=0.002) and multiple steroid pulses (P=0.05). These data provide information on the course of recurrent hepatitis C and may be helpful to individualize the treatment of transplanted patients. © 2004 European Association for the Study of the Liver. Published by Elsevier B.V. All rights reserved.
引用
收藏
页码:862 / 863
页数:2
相关论文
共 8 条
[1]   Contribution of donor age to the recent decrease in patient survival among HCV-infected liver transplant recipients [J].
Berenguer, M ;
Prieto, M ;
San Juan, F ;
Rayón, JM ;
Martinez, F ;
Carrasco, D ;
Moya, A ;
Orbis, F ;
Mir, J ;
Berenguer, J .
HEPATOLOGY, 2002, 36 (01) :202-210
[2]   European collaborative study on factors influencing outcome after liver transplantation for hepatitis C [J].
Féray, C ;
Caccamo, L ;
Alexander, GJM ;
Ducot, B ;
Gugenheim, J ;
Casanovas, T ;
Loinaz, C ;
Gigou, M ;
Burra, P ;
Barkholt, L ;
Esteban, R ;
Bizollon, T ;
Lerut, J ;
Minello-Franza, A ;
Bernard, PH ;
Nachbaur, G ;
Botta-Fridlund, D ;
Bismuth, H ;
Schalm, SW ;
Samuel, D .
GASTROENTEROLOGY, 1999, 117 (03) :619-625
[3]   The association between hepatitis C infection and survival after orthotopic liver transplantation [J].
Forman, LM ;
Lewis, JD ;
Berlin, JA ;
Feldman, HI ;
Lucey, MR .
GASTROENTEROLOGY, 2002, 122 (04) :889-896
[4]   Genetic clustering of hepatitis C virus strains and severity of recurrent hepatitis after liver transplantation [J].
Gigou, M ;
Roque-Afonso, AM ;
Falissard, B ;
Penin, F ;
Dussaix, E ;
Féray, C .
JOURNAL OF VIROLOGY, 2001, 75 (23) :11292-11297
[5]  
Neumann UP, 2004, J HEPATOL, V41, P830, DOI 10.1016/j.jhep.2004.06.029
[6]   Long-term outcome of liver transplants for chronic hepatitis C: A 10-year follow-up [J].
Neumann, UP ;
Berg, T ;
Bahra, M ;
Puhl, G ;
Guckelberger, O ;
Langrehr, JM ;
Neuhaus, P .
TRANSPLANTATION, 2004, 77 (02) :226-231
[7]   Natural history of liver fibrosis progression in patients with chronic hepatitis C [J].
Poynard, T ;
Bedossa, P ;
Opolon, P .
LANCET, 1997, 349 (9055) :825-832
[8]   Donor age influences 10-year liver graft histology independently of hepatitis C virus infection [J].
Rifai, K ;
Sebagh, M ;
Karam, V ;
Saliba, F ;
Azoulay, D ;
Adam, R ;
Castaing, D ;
Bismuth, H ;
Reynès, M ;
Samuel, D ;
Féray, C .
JOURNAL OF HEPATOLOGY, 2004, 41 (03) :446-453